Constellation Brands (STZ) shares slumped 7% Tuesday after the alcoholic beverage giant cut its outlook on falling demand for beer and the impact of tariffs.
Constellation Brands (NYSE: STZ), the beverage giant behind popular beer labels such as Modelo and Corona, lowered its full-year fiscal 2026 guidance on Tuesday, citing a challenging macroeconomic backdrop and slowing consumer demand. The announcement triggered a sharp sell-off, with shares falling about 7.3% and hitting its 52-week low.
Constellation Brands cut its fiscal year guidance on Tuesday, citing a "challenging macroeconomic environment." The company also reported a decline in sales among Hispanic consumers, who it has said make up about half of its beer sales.
The consumer staples sector has faced some significant challenges in recent months. Cost pressures due to persistent inflation, high commodity prices, and tariffs have damaged profit margins, while real average wages have fallen and caused consumers to tighten belts.
Shares of Constellation Brands Inc. were dropping in early Tuesday trading toward the lowest levels seen since the height of the COVID-19 pandemic, as the beer maker issued a profit and sales warning, citing a sudden drop in sales.
Updates reported EPS guidance to $10.77 - $11.07 and comparable EPS guidance to $11.30 - $11.60 (1) Updates Enterprise organic net sales to decline (6)% - (4)%, reported operating income to grow 666% - 686% and comparable operating income to decline (11)% - (9)% Updates Beer net sales to decline (4)% - (2)% and Beer operating income to decline (9)% - (7)% ROCHESTER, N.Y., Sept. 02, 2025 (GLOBE ...
Warren Buffett turned Berkshire Hathaway (BRK.A 0.66%) (BRK.B 0.63%) into a trillion-dollar company primarily by investing in stocks. "That preference won't change," Buffett wrote in his most recent letter to shareholders.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.